Companies / Ocular Therapeutix, Inc / Activity
Activity — Ocular Therapeutix, Inc
56 moves.
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | Dugel Pravin Executive | Sell | Common Stock | $1.13M | -125K -3.95% | 3,033,078 1.38% of shares | medium |
| Feb 20, 2026 | Lindstrom Richard L Md Director | Buy | Common Stock | $461.4K | +60K +32.26% | 246,933 0.11% of shares | medium |
| May 26, 2026 | Dugel Pravin Executive | Sell | Common Stock | $173.5K | -21K -0.81% | 2,597,170 1.18% of shares | medium |
| Feb 23, 2026 | Dugel Pravin Executive | Sell | Common Stock | $166.1K | -20K -0.66% | 3,013,022 1.37% of shares | medium |
| Jun 3, 2026 | Waheed Nadia Executive | Sell | Common Stock | $122.6K | -15K -4.71% | 300,079 0.14% of shares | medium |
| Feb 12, 2026 | Notman Donald Executive | Sell | Common Stock | $103.5K | -11K -3.03% | 366,356 0.17% of shares | medium |
| Feb 12, 2026 | Nayak Sanjay Executive | Sell | Common Stock | $93.5K | -10K -3.02% | 332,412 0.15% of shares | low |
| Feb 12, 2026 | Waheed Nadia Executive | Sell | Common Stock | $71.1K | -8K -2.41% | 318,417 0.14% of shares | low |
| Feb 4, 2026 | Notman Donald Executive | Sell | Common Stock | $51.5K | -6K -1.57% | 377,802 0.17% of shares | low |
| Feb 2, 2026 | Notman Donald Executive | Sell | Common Stock | $49.9K | -5K -1.40% | 383,837 0.17% of shares | low |
| Feb 20, 2026 | Waheed Nadia Executive | Sell | Common Stock | $27.2K | -4K -1.10% | 314,907 0.14% of shares | low |
| Feb 23, 2026 | Heier Jeffrey S. Executive | Sell | Common Stock | $25.3K | -3K -0.94% | 323,368 0.15% of shares | low |
| May 26, 2026 | Heier Jeffrey S. Executive | Sell | Common Stock | $24.7K | -3K -0.93% | 320,350 0.15% of shares | low |
| May 26, 2026 | Kaiser Peter Executive | Sell | Common Stock | $24.3K | -3K -1.10% | 266,141 0.12% of shares | low |
| Feb 23, 2026 | Kaiser Peter Executive | Sell | Common Stock | $23.3K | -3K -1.03% | 269,108 0.12% of shares | low |
| May 26, 2026 | Nayak Sanjay Executive | Sell | Common Stock | $15.2K | -2K -0.56% | 328,795 0.15% of shares | low |
| Feb 23, 2026 | Nayak Sanjay Executive | Sell | Common Stock | $14.6K | -2K -0.53% | 330,653 0.15% of shares | low |
| Jun 16, 2026 | Dugel Pravin Executive | Gift | Common Stock | $0 | +50K | 50,092 0.02% of shares | low |
| Jun 16, 2026 | Dugel Pravin Executive | Gift | Common Stock | $0 | -50K -1.93% | 2,547,078 1.16% of shares | low |
| Jun 10, 2026 | Robins Jason Shand Executive | Grant | Common Stock | $0 | +15K +29.32% | 68,097 0.03% of shares | low |
| Jun 10, 2026 | Hong Seung Suh Director | Grant | Common Stock | $0 | +14K +29.83% | 60,933 0.03% of shares | low |
| Jun 10, 2026 | Williams Leslie J. Director | Grant | Common Stock | $0 | +14K +27.22% | 65,433 0.03% of shares | low |
| May 28, 2026 | Dugel Pravin Executive | Gift | Common Stock | $0 | +395K +131.51% | 694,811 0.32% of shares | low |
| May 28, 2026 | Dugel Pravin Executive | Gift | Common Stock | $0 | -395K -100.00% | 0 0.00% of shares | low |
| Apr 9, 2026 | Dugel Pravin Executive | Gift | Common Stock | $0 | +395K | 394,696 0.18% of shares | low |
| Apr 9, 2026 | Dugel Pravin Executive | Gift | Common Stock | $0 | -395K -13.10% | 2,618,326 1.19% of shares | low |
| Jun 10, 2026 | Warden Charles M Director | Grant | Common Stock | $0 | +14K +16.19% | 100,464 0.05% of shares | low |
| Jun 10, 2026 | Graves Adrienne L Director | Grant | Common Stock | $0 | +14K +28.00% | 64,000 0.03% of shares | low |
| Jun 10, 2026 | Lindstrom Richard L Md Director | Grant | Common Stock | $0 | +14K +5.67% | 260,933 0.12% of shares | low |
| Jun 10, 2026 | Raines Merilee Director | Grant | Common Stock | $0 | +14K +29.83% | 60,933 0.03% of shares | low |
| Jan 2, 2026 | Notman Donald Executive | Grant | Common Stock | $0 | +79K +25.51% | 389,292 0.18% of shares | low |
| Jan 2, 2026 | Heier Jeffrey S. Executive | Grant | Common Stock | $0 | +79K +31.99% | 326,425 0.15% of shares | low |
| Jan 21, 2026 | Robinson David Wayne Executive | Grant | Common Stock | $0 | +136K | 136,000 0.06% of shares | low |
| Jan 2, 2026 | Anderman Todd Executive | Grant | Common Stock | $0 | +65K +74.11% | 152,468 0.07% of shares | low |
| Jan 2, 2026 | Meyers Steve Lawrence Executive | Grant | Common Stock | $0 | +65K +42.49% | 217,628 0.10% of shares | low |
| Jan 2, 2026 | Nayak Sanjay Executive | Grant | Common Stock | $0 | +65K +23.36% | 342,760 0.16% of shares | low |
| Jan 2, 2026 | Kaiser Peter Executive | Grant | Common Stock | $0 | +79K +41.03% | 271,918 0.12% of shares | low |
| Jan 2, 2026 | Saroj Namrata Executive | Grant | Common Stock | $0 | +79K +45.08% | 254,620 0.12% of shares | low |
| Jan 2, 2026 | Waheed Nadia Executive | Grant | Common Stock | $0 | +79K +32.01% | 326,280 0.15% of shares | low |
| Jun 10, 2026 | Robins Jason Shand Executive | Grant | Stock Option (Right to Buy) | — | +14K | 14,024 <0.01% of shares | low |
| Jun 10, 2026 | Hong Seung Suh Director | Grant | Stock Option (Right to Buy) | — | +44K | 44,000 0.02% of shares | low |
| Jun 10, 2026 | Williams Leslie J. Director | Grant | Stock Option (Right to Buy) | — | +44K | 44,000 0.02% of shares | low |
| Jun 10, 2026 | Warden Charles M Director | Grant | Stock Option (Right to Buy) | — | +44K | 44,000 0.02% of shares | low |
| Jun 10, 2026 | Graves Adrienne L Director | Grant | Stock Option (Right to Buy) | — | +44K | 44,000 0.02% of shares | low |
| Jun 10, 2026 | Lindstrom Richard L Md Director | Grant | Stock Option (Right to Buy) | — | +44K | 44,000 0.02% of shares | low |
| Jun 10, 2026 | Raines Merilee Director | Grant | Stock Option (Right to Buy) | — | +44K | 44,000 0.02% of shares | low |
| Jan 2, 2026 | Notman Donald Executive | Grant | Stock Option (Right to Buy) | — | +241K | 240,932 0.11% of shares | low |
| Jan 2, 2026 | Heier Jeffrey S. Executive | Grant | Stock Option (Right to Buy) | — | +241K | 240,932 0.11% of shares | low |
| Jan 21, 2026 | Robinson David Wayne Executive | Grant | Stock Option (Right to Buy) | — | +416K | 416,000 0.19% of shares | low |
| Jan 20, 2026 | Robins Jason Shand Executive | Grant | Stock Option (Right to Buy) | — | +33K | 33,000 0.02% of shares | low |